Sutro Biopharma Inc (STRO)

10:41 AM

Sutro Biopharma CEO unveils expanding ADC pipeline and key cancer partnerships - Traders Union

10:41 AM

May 25, 2026

Sutro Biopharma (STRO) price target increased by 1,325.54% to 39.05 - MSN

May 25, 2026

May 22, 2026

Sutro Biopharma (STRO) Consolidates Near Resistance: Biotech Stock Shows Modest GainsSocial Trading Insights - Newser

May 22, 2026

May 21, 2026

Sutro Biopharma (STRO) Sees Minor Dip, Holds Above Key SupportWyckoff Accumulation - Newser

May 21, 2026

May 21, 2026

STRO SEC FilingsSutro Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan

May 21, 2026

May 17, 2026

US$47.10That's What Analysts Think Sutro Biopharma, Inc. (NASDAQ:STRO) Is Worth After These Results - Yahoo Finance

May 17, 2026

May 16, 2026

Update: Sutro Biopharma Shares Rise After Q1 Loss Narrows - Moomoo

May 16, 2026

May 16, 2026

STRO Maintained by HC Wainwright & Co. -- Price Target Raised to $50 - GuruFocus

May 16, 2026

May 15, 2026

STRO Upgraded by Wedbush -- Price Target Raised to $60 - GuruFocus

May 15, 2026

May 15, 2026

Is Sutro Biopharma (STRO) 189.6% Overvalued After Q1 2026? EPS b - GuruFocus

May 15, 2026

May 15, 2026

Sutro Biopharma (STRO) affiliates disclose 1.06M shares; ownership details - Stock Titan

May 15, 2026

May 15, 2026

Kynam Capital reports 5.27% stake in Sutro Biopharma (NASDAQ: STRO) - Stock Titan

May 15, 2026

May 15, 2026

STRO Maintained by Leerink Partners -- Price Target Raised to $4 - GuruFocus

May 15, 2026

May 15, 2026

Sutro Biopharma Shares Rise After Q1 Loss Narrows - marketscreener.com

May 15, 2026

May 15, 2026

Gemini Space posts upbeat Q1 results, joins Figma, Sutro Biopharma and other big stocks moving higher on Friday - MSN

May 15, 2026

May 15, 2026

Wedbush Upgrades Sutro Biopharma to Outperform From Neutral, Boosts Price Target to $60 From $22 - Moomoo

May 15, 2026

May 15, 2026

Gemini Space Posts Upbeat Q1 Results, Joins Figma, Sutro Biopharma And Other Big Stocks Moving Higher On Friday - Benzinga

May 15, 2026

May 15, 2026

Sutro Biopharma, Inc. Stock 12‑Month Price Target Raised to $41.64, Implies 8% Upside - TradingView

May 15, 2026

May 15, 2026

Sutro Biopharma (STRO) Q1 Revenue Surpasses Expectations - GuruFocus

May 15, 2026

May 14, 2026

Sutro Biopharma Q1 Loss Narrows, Revenue Declines - Moomoo

May 14, 2026

May 14, 2026

Sutro Biopharma (NASDAQ: STRO) narrows Q1 loss and boosts cash with $110M share sale - Stock Titan

May 14, 2026

May 14, 2026

Sutro Biopharma releases first quarter financials and updates business outlook - Traders Union

May 14, 2026

May 14, 2026

Net loss narrows as Sutro Biopharma (NASDAQ: STRO) boosts cash into 2028 - Stock Titan

May 14, 2026

May 14, 2026

Sutro Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

Affinity Asset Advisors (NASDAQ: STRO) discloses 6.5% stake - Stock Titan

May 14, 2026

May 14, 2026

Cancer-drug maker Sutro projects cash runway into 2028 as ADC pipeline advances - Stock Titan

May 14, 2026

May 14, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights - marketscreener.com

May 14, 2026

May 12, 2026

Wedbush Raises Price Target on Sutro Biopharma to $22 From $10, Keeps Neutral Rating - Moomoo

May 12, 2026

May 12, 2026

MSN Money - MSN

May 12, 2026

May 11, 2026

Certain Warrants of Sutro Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2026. - marketscreener.com

May 11, 2026

May 11, 2026

Certain Options of Sutro Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2026. - marketscreener.com

May 11, 2026

May 08, 2026

How sustainable is Sutro Biopharma (STRO) profit margins? (Runs Up) 2026-05-08High Attention Stocks - newser.com

May 08, 2026

May 08, 2026

Is Sutro Biopharma (STRO) building a durable competitive moat? (+5.68%) 2026-05-08Seasonality Effect - Newser

May 08, 2026

May 07, 2026

Sutro Biopharma (STRO) Eps Diluted (TTM) - Zacks Investment Research

May 07, 2026

May 07, 2026

Sutro Biopharma (STRO) to Release Earnings on Thursday - MarketBeat

May 07, 2026

May 06, 2026

Sutro Biopharma (NASDAQ:STRO) Stock Rating Upgraded by Truist Financial - MarketBeat

May 06, 2026

May 04, 2026

Sutro Biopharma Inc expected to post a loss of $3.77 a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

STRO Sutro Biopharma slips 2.81% as its Q4 2025 loss lands 19.4% below analyst consensus estimates.Credit Risk - newser.com

May 03, 2026

May 02, 2026

Sutro Biopharma (NASDAQ:STRO) Upgraded at Lifesci Capital - MarketBeat

May 02, 2026

May 02, 2026

Citizens Raises Sutro Biopharma Price Target to 41 Dollars - HarianBasis.co

May 02, 2026

May 01, 2026

Point72 group (NASDAQ: STRO) reports 5.7% stake — 946,829 shares - Stock Titan

May 01, 2026

May 01, 2026

Sutro Biopharma (NASDAQ:STRO) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat

May 01, 2026

May 01, 2026

Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program - Insider Monkey

May 01, 2026

May 01, 2026

Mizuho initiates coverage of Sutro Biopharma (STRO) with outperform recommendation - MSN

May 01, 2026

Apr 30, 2026

Sutro Biopharma: Recycling Past Data Ahead Of The Readout, Sell - Seeking Alpha

Apr 30, 2026

Apr 30, 2026

This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday - Benzinga

Apr 30, 2026